PrasannaJagannathanMD

Assistant Professor, Medicine, University of California, San Francisco, School of

Dr. Jagannathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of California (San Francisco)Fellowship, Infectious Disease, 2009 - 2011
University of California (San Francisco)Residency, Internal Medicine, 2005 - 2009
Harvard Medical SchoolClass of 2005

PubMed

56 citations
SARS-CoV-2 Antiviral Therapy.
Kaiming Tao, Philip L Tzou, Janin Nouhin, Hector Bonilla, Prasanna Jagannathan
Clinical Microbiology Reviews. 2021-07-28
71 citations
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity.
Saborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, Vamsee Mallajosyula, Srijoni Chakraborty
Science Translational Medicine. 2022-03-09
106 citations
Proinflammatory IgG Fc structures in patients with severe COVID-19.
Saborni Chakraborty, Joseph C. Gonzalez, Karlie Edwards, Vamsee Mallajosyula, Anthony S. Buzzanco
Nature Immunology. 2021-01-01

Journal Articles

Dihydroartemisinin-Piperaquine for Intermittent Preventive Treatment of Malaria During Pregnancy and Risk of Malaria in Early Childhood: A Randomized Controlled Trial
Bryan Greenhouse, Prasanna Jagannathan, Diane V Havlir, PLoS One

I Didn’t Take Paxlovid and Got Rebound COVID Anyway. Did I Make the Wrong Call?September 5th, 2022
Paxlovid for COVID-19: Important InformationJuly 14th, 2022
Paxlovid: Your Questions About the Antiviral COVID-19 Pill Treatment, AnsweredJuly 14th, 2022
Join now to see all